Genmab — September 2018
-
-
404: This page could not be found.BerGenBio - Developing first-in-class AXL inhibitors for aggressive disease
BerGenBio: Developing first-in-class AXL inhibitors for aggressive diseases, including advanced, treatment resistant cancers
(www.bergenbio.com)
-
-
@Sukkeralf. Jeg er bare overrasket over man ikke kan få en bedre aftale selvom det er den første. Købte JnJ sig ikke til 20 skud i bøssen i sin tid. Med lidt tillid til egen platform, havde jeg håbet på højere royalties. Never mind. Dit link kan jeg i øvrigt ikke få til at virke.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
antibody platform